drugset / Trial / NCT01925261
A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees
RandomizedFactorialQuadruple-blindTreatment
Summary
This one-year study is designed to investigate the safety and efficacy of TPX-100, a 23-amino acid chondrogenic peptide, delivered by intra-articular injection, in regeneration of knee cartilage in subjects with bilateral osteoarthritis of the knee.
Timeline
- Start
- 2014-01
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TPX-100 | Peptide | 20 mg | Intrathecal |
| Comparator | TPX-100 | Peptide | 50 mg | Intrathecal |
| Comparator | TPX-100 | Peptide | 100 mg | Intrathecal |
| Comparator | TPX-100 | Peptide | 200 mg | Intrathecal |